story of the week
Commercialization of Generic Angiotensin II Receptor Blockers Associated With an Increase in Adverse Events
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation: Cardiovascular Quality and Outcomes
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of the Commercialization of Three Generic Angiotensin II Receptor Blockers on Adverse Events in Quebec, Canada: A Population-Based Time Series Analysis
Circ Cardiovasc Qual Outcomes 2017 Oct 01;10(10)e003891, J Leclerc, C Blais, L Rochette, D Hamel, L Guénette, P PoirierFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.